Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | TDP2 | O95551 | 2/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.40 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.39 |
| ▸ | AXL | P30530 | 1/20 | 0.39 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.39 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.39 |
| ▸ | KMO | O15229 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9973724 | 0.97 | PDK2 (0.50) | PDK2CYP2A6CYP3A4TDP2CYP11B1 | |
| SCHEMBL9973778 | 0.88 | PDK2 (0.52) | PDK2CYP2A6CYP3A4TDP2CYP11B1 | |
| SCHEMBL2018423 | 0.88 | PDK2 (0.42) | PDK2CYP2A6CYP3A4TDP2CYP11B1 | |
| SCHEMBL9973734 | 0.88 | CYP2A6 (0.46) | PDK2CYP2A6CYP3A4TDP2CYP11B1 | |
| SCHEMBL9973736 | 0.86 | PDK2 (0.57) | PDK2CYP2A6CYP3A4TDP2CYP11B1 | |
| SCHEMBL15977516 | 0.85 | PDK2 (0.45) | PDK2CYP2A6CYP3A4TDP2CYP11B1 | |
| SCHEMBL19164154 | 0.85 | PDK2 (0.56) | PDK2CYP2A6CYP3A4TDP2CYP11B1 | |
| SCHEMBL19164112 | 0.85 | PDK2 (0.56) | PDK2CYP2A6CYP3A4TDP2CYP11B1 | |
| SCHEMBL12575125 | 0.84 | CYP11B1 (0.43) | PDK2CYP2A6CYP3A4TDP2CYP11B1 | |
| SCHEMBL15977588 | 0.84 | PDK2 (0.44) | PDK2CYP2A6CYP3A4TDP2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8202633-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2012-06-19 | — | — | US | disclosed |
| US-8202633-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2012-06-19 | — | — | US | disclosed |
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SK MATERIALS JNC CO., LTD. (KR) | 2011-09-08 | — | — | US | disclosed |
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SK MATERIALS JNC CO., LTD. (KR) | 2011-09-08 | — | — | US | disclosed |
| US-7964293-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-7964293-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SK MATERIALS JNC CO., LTD. (KR) | 2009-05-28 | — | — | US | disclosed |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SK MATERIALS JNC CO., LTD. (KR) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SLC25A11, ELAVL1, SLC26A3 | PDK2 4209/4885CYP2A6 4405/4885CYP3A4 1526/4885 |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SLC25A11, ELAVL1, SLC26A3 | PDK2 4209/4885CYP2A6 4405/4885CYP3A4 1526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.